Skip to content
Open access

When DL-Based Prescreening Meets Synthon-Based Docking: Target-Adapting PharmacoNet via MEL-Steered Correction

Sep 2026 · bioRxiv · 0 citations · 17 references
Biology

TL;DR

MEL-Steered PharmacoNet is introduced, a parameter-efficient adaptation framework that specializes PharmacoNet to a given target through two composable mechanisms: empirical density-map steering of predicted pharmacophore hotspots and empirical fine-tuning of interaction-type scoring weights.

Abstract

As chemical libraries expand into the trillions of molecules, Virtual SYNthon Hierarchical Enumeration Screening (V-SYNTHES) has emerged as a leading strategy for making gigascale virtual screening computationally tractable. In V-SYNTHES, a Minimal Enumeration Library (MEL) of chemical fragments is docked against a target first, and only the top-scoring fragments are expanded into full ligands for large-scale docking. However, among the large number of comparably well-docked fragments, only a small fraction can be expanded under a fixed docking budget, leaving most similarly promising fragments unexplored. General-purpose prescreening tools can be adopted to address this constraint, reallocating the same docking budget across a larger pool of fragments’ enumerated full ligands by their proxy score. However, such tools are applied with-out accounting for target-specific pocket environments. One such method, PharmacoNet, predicts interaction hotspots from a protein structure and ranks candidates via graph matching against a fixed set of interaction-type weights. We recognize that V-SYNTHES’s initial fragment-docking step, ordinarily used only for selection of best fragments for expansion, already reveals which of these hotspots and interaction types a given pocket actually favors, and we can recover this signal to fine-tune PharmacoNet accordingly. We introduce MEL-Steered PharmacoNet, a parameter-efficient adaptation framework that specializes PharmacoNet to a given target through two composable mechanisms: (i) empirical density-map steering of predicted pharmacophore hotspots, and (ii) empirical fine-tuning of interaction-type scoring weights. Across three structurally distinct GPCR targets (CB2, GPR91, 5-HT2AR), MEL-Steered PharmacoNet achieves substantial enrichment factor (EF100) gains over a random baseline, and improves EF100 over PharmacoNet by 8.94×, 6.87×, and 1.69×, respectively. The fitted per-target weights further reveal distinct, chemically interpretable interaction profiles that PharmacoNet’s generic fixed weights fail to capture. These results show that fragment-docking data already generated by the standard V-SYNTHES pipeline can adapt a general-purpose pharmacophore prescreening method to an individual target, significantly improving its performance while retaining its ultra-fast screening ability, with no additional experimental data or model retraining.

Read PDF

Similar papers

Open access Sep 2026

Data driven selection of consensus docking pipelines for structure based hit identification

MolDockLab addresses the challenge of structure-based virtual screening with an automated, data-driven framework that optimizes SBVS workflows for a protein target, balancing predictive performance and computational efficiency.

Hamza Agha, Y. Ibrahim, Michael Backenköhler et al. · 0 citations
Open access Sep 2026

AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

AdaptiveFlow enables drug discovery at unprecedented scale and supports the development of AI-driven methods, and identifies nanomolar inhibitors of two disease-relevant targets, ferroptosis suppressor protein 1 and poly(ADP-ribose) polymerase 1.

Domiziana Cecchini, AkshatKumar Nigam, Ming Tang et al. · 1 citation
Open access Sep 2026

ReverseScreen.ai: Pharmacophore-Guided Reverse Screening Across the Growing Co-Complex Proteome

Biopharmaceutical companies routinely use forward screening to identify potential ligands for argets of biological consequence. Increasingly, they are also using reverse screening to proactively identify downstream off-target liabilities and new repurposing opportunities. Exhaustive reverse docking of one or a multitud...

Steven M. Muskal, G. Nicola · 2 citations
Open access Sep 2026

Pushing the boundaries of virtual screening scale of combinatorial spaces with the V-SYNTHES approach

The first application of the V-SYNTHES2 synthon-based screening approach to the 173-billion-compound Enamine xREAL Space is reported, demonstrating near-linear computational scaling with only a 10–15% increase in cost relative to the 11-billion-compound REAL Space.

Mykola V. Protopopov, Olha Semenenko, Maryna Vasylchuk et al. · 0 citations
#artificial intelligence Preprint Sep 2026

TopU-LBVS: A Realistic Multi Target Benchmark for Ligand Based Virtual Screening

TopU-LBVS is introduced, a multi-target benchmark for LBVS under hard-negative screening conditions, and fixed splits, evaluation code, and baseline implementations are released for reproducible comparison of future LBVS and molecular representation learning methods.

Surbhi Kumar, Yu-He Zhou, V. Shiralkar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.